Vasomotor Symptoms (VMS)
9 clinical trials · Condition
◉ Watch Vasomotor Symptoms (VMS)
| Record | Firm | Date |
|---|---|---|
| Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor (NCT03518138) | Que Oncology | 2018-10-24 |
| Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms (NCT03541200) | Tanabe Pharma America, Inc. | 2018-04-18 |
| Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen (NCT04080297) | Que Oncology | 2014-01-10 |
| Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS) (NCT02049164) | Arbor Pharmaceuticals, Inc. | 2014-01-01 |
Track Vasomotor Symptoms (VMS) automatically
Every clearance here is in the API, with alerts when new ones post.